RAB33A promotes metastasis via RhoC accumulation through non-canonical autophagy in cervical cancer

  • 0State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.

|

|

Summary

This summary is machine-generated.

Researchers discovered that RAB33A promotes cervical cancer metastasis by stabilizing RhoC through non-canonical autophagy. High RAB33A expression indicates a poorer prognosis, suggesting RhoC inhibitors as potential treatments.

Area Of Science

  • Molecular Oncology
  • Cell Biology
  • Cancer Metastasis Research

Background

  • Cervical cancer metastasis involves the systemic spread of tumor cells, but the precise mechanisms are not fully elucidated.
  • Understanding the molecular drivers of metastasis is crucial for developing effective therapeutic strategies.

Purpose Of The Study

  • To investigate the role of RAB33A in promoting cervical cancer metastasis.
  • To elucidate the molecular mechanisms by which RAB33A influences tumor cell spread.
  • To explore the prognostic significance of RAB33A expression in cervical cancer patients.

Main Methods

  • Investigated the interaction between RAB33A and RhoC in cervical cancer cells.
  • Analyzed the impact of RAB33A on autophagy pathways, specifically canonical versus non-canonical autophagy.
  • Examined the effect of RAB33A on the degradation of RhoC and lysosomal fusion.
  • Correlated RAB33A expression levels with patient prognosis.

Main Results

  • RAB33A was found to promote cervical cancer metastasis by increasing RhoC accumulation.
  • RAB33A induced non-canonical autophagy, stabilizing RhoC and facilitating pseudopodia formation.
  • RAB33A impaired autophagosome-lysosome fusion by inactivating RAB7 via TBC1D2A.
  • Higher RAB33A expression was significantly associated with poorer patient prognosis.

Conclusions

  • The RAB33A-RhoC axis plays a critical role in driving cervical cancer metastasis.
  • Targeting RhoC may be a viable therapeutic strategy for cervical cancer patients with elevated RAB33A levels.

Related Concept Videos

Small GTPases - Ras and Rho 01:24

3.9K

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:

Guanine nucleotide exchange factors or GEF,
GTPase-activating proteins or GAPs, and
Guanine nucleotide-dissociation inhibitors or GDIs.

The GEF activates the GTPase by exchanging the bound-GDP with GTP. The...

mTOR Signaling and Cancer Progression 03:03

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cell Polarization by Rho Proteins 01:21

2.6K

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

The <em>Ras</em> Gene 02:38

6.1K

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Abnormal Proliferation 02:23

4.4K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...